Lidanserin (; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist. It was developed as an antihypertensive agent but was never marketed.
See also Serotonin 5-HT2A receptor antagonist Glemanserin Pruvanserin Roluperidone Volinanserin Lenperone Iloperidone Ketanserin 4F-4PP
References